Physician profile
Katheryn E Sarantos
NPI 1982628632
$2,388.94
in general payments reported to CMS, 2019-2025
23 companies · $304 in 2025
The $304 reported for 2025 was more than what 85% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $286 · 2021: $533 · 2022: $414 · 2023: $308 · 2024: $266 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $878.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $878.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $522.73 | 2021-2025 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $439.33 | 2019-2024 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $224.49 | 2019-2022 | |
| Glaxosmithkline, LLC. | $151.89 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $138.71 | 2023-2024 | Flumist Quadrivalent, Evusheld |
| Neos Therapeutics, Lp | $129.44 | 2019-2023 | Adzenys Xr-Odt |
| Sobi, INC | $115.37 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $109.27 | 2019-2024 | Gardasil 9, Gardasil, Vaxelis |
| Collegium Pharmaceutical, INC. | $99.76 | 2025 | Jornay Pm |
| Tris Pharma INC | $93.55 | 2019-2020 | |
| Kaleo, INC. | $70.32 | 2021-2022 | |
| Sanofi Pasteur INC. | $51.41 | 2021-2025 | |
| Biomarin Pharmaceutical INC. | $48.91 | 2025 | Voxzogo 1.2mg |
| Pfizer INC. | $46.15 | 2021-2023 | |
| Seqirus USA INC | $28.29 | 2021-2025 | Flucelvax |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $20.62 | 2021 | |
| Noven Pharmaceuticals, INC. | $18.09 | 2024 | Xelstrym |
| Ultragenyx Pharmaceutical INC. | $15.96 | 2020 | |
| Corium, LLC | $15.00 | 2022 | |
| Adlon Therapeutics L.P. | $13.90 | 2020 | |
| Mylan Pharmaceuticals INC. | $12.50 | 2019 | |
| Shire North American Group INC | $12.14 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katheryn Sarantos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.